Peritoneal DialysisPeritoneal Dialysis, Continuous AmbulatoryDialysis SolutionsRenal DialysisPeritonitisPeritoneumKidney Failure, ChronicDialysisCatheters, IndwellingUltrafiltrationHemodialysis SolutionsPeritoneal DiseasesPeritoneal FibrosisUreaGlucansPeritoneal CavityAnuriaCreatinineHemodialysis, HomeTime FactorsUremiaAscitic FluidSerum AlbuminRetrospective StudiesProspective StudiesCatheterizationGlucoseTreatment OutcomeRenal Replacement TherapyBicarbonatesEquipment FailureNephrologyBody Surface AreaWater-Electrolyte ImbalanceFollow-Up StudiesCefazolinHemodiafiltrationRisk FactorsSclerosisAutomationKidney DiseasesSurvival RateBody WaterSterilizationWater-Electrolyte BalanceKidney TransplantationNutritional StatusOmentumInfusions, ParenteralBacterial InfectionsGlucose Solution, HypertonicHydrothoraxBuffersDiabetic NephropathiesAcute Kidney InjuryBiological TransportErythropoietinStaphylococcus epidermidisAbsorptionTreatment FailureDevice RemovalRenal InsufficiencyGlycosylation End Products, AdvancedAnemiaRenal OsteodystrophyBlood Urea NitrogenKidney Function TestsPermeabilityAnterior Eye SegmentCohort StudiesMupirocinIncidenceBiocompatible MaterialsProtein-Energy MalnutritionKidneyGlomerular Filtration RatePrescriptionsHemodialysis Units, HospitalProportional Hazards ModelsElectric ImpedanceArteriovenous Shunt, SurgicalHypoalbuminemiaCross-Over StudiesRod Cell Outer SegmentKidneys, ArtificialBiological MarkersSurvival AnalysisMembranes, ArtificialHematinicsFuraldehydeInjections, IntraperitonealRenal Insufficiency, ChronicCross-Sectional StudiesMetabolic Clearance Ratebeta 2-MicroglobulinHemoglobinsPhosphorusHemofiltrationAnti-Bacterial AgentsQatar